Trial Profile
Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Nov 2020
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Quetiapine (Primary) ; Risperidone (Primary) ; Citalopram
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms CATIE-AD
- 12 Nov 2020 Results (n=108) of analysis assessing pharmacokinetic profiles of risperidone and 9-hydroxy (OH)-risperidone and how these related to treatment emergent extrapyramidal side effects published in the British Journal of Psychiatry
- 17 Oct 2017 Results of post hoc analysis (n=371) assessing placebo effects in the treatment of noncognitive symptoms of alzheimer's disease, were published in the Journal of Clinical Psychiatry.
- 05 Nov 2010 New trial record.